HOMA-IR: How to Calculate and Read Your Insulin Resistance Score

Quick answer: HOMA-IR (Homeostatic Model Assessment of Insulin Resistance) is a single number calculated from a fasting glucose and a fasting insulin draw. The formula is: fasting insulin (microIU/mL) multiplied by fasting glucose (mg/dL), divided by 405. A score below 1.0 is considered optimal in most research. A score of 1.0 to 1.9 is borderline. Anything at or above 2.0 signals meaningful insulin resistance that warrants action and a conversation with a clinician.

What Is HOMA-IR and Why Does It Exist?

HOMA-IR quantifies how hard your pancreas is working to keep blood sugar in range. The model was developed by Matthews and colleagues at Oxford in 1985 as a way to estimate insulin resistance without an invasive glucose clamp study. The idea: in a truly fasted state, your glucose and insulin levels reach a steady equilibrium. High fasting insulin with normal or elevated fasting glucose means the pancreas is overcompensating for cells that have stopped listening. The ratio captures that signal in one digestible score.

What makes HOMA-IR clinically valuable is its sensitivity. A1C and fasting glucose alone do not catch insulin resistance until the pancreas is already struggling. HOMA-IR can flag the problem five to ten years earlier, when lifestyle changes still have maximum impact. The fasting insulin test is the hidden half of the equation that most routine labs skip entirely, which is why most people have never heard of HOMA-IR despite it appearing in thousands of peer-reviewed papers.

How to Calculate HOMA-IR: The Exact Formula

The HOMA-IR formula has one version for US labs (mg/dL glucose) and a slightly different constant for labs using mmol/L. Since US results from Quest and Labcorp report glucose in mg/dL, use this version:

HOMA-IR = (Fasting Insulin in microIU/mL x Fasting Glucose in mg/dL) / 405

A worked example: suppose your fasting insulin comes back at 9 microIU/mL and your fasting glucose is 92 mg/dL.

• 9 x 92 = 828
• 828 / 405 = 2.04
• HOMA-IR = 2.04, which puts you in the insulin-resistant range despite a perfectly normal fasting glucose.

If your lab reports glucose in mmol/L (common in Canada and the UK), the divisor changes to 22.5 instead of 405. Most online HOMA-IR calculators handle unit conversion automatically. The key is always using the fasting values, not a random draw taken after a meal.

One practical note: fasting insulin assays are not standardized across labs the way glucose assays are. Quest and Labcorp use slightly different reference methods, and a value of 9 from Quest may not be identical to a 9 from a hospital CLIA lab. For tracking your own trend over time, staying with the same lab matters more than the absolute number.

HOMA-IR Normal Range: What the Research Actually Says

There is no single FDA-approved normal range for HOMA-IR, which confuses a lot of patients. Labs often do not even report it on a standard panel. The ranges below come from population research and longevity-oriented clinical practice, not a single regulatory cutoff:

HOMA-IR Score	Interpretation	What It Likely Means
Below 1.0	Optimal	High insulin sensitivity; cells respond efficiently to insulin
1.0 to 1.4	Normal (population average)	Typical for a metabolically healthy US adult; not alarming but not optimal
1.5 to 1.9	Early insulin resistance	Borderline; worth addressing with diet, exercise, and a follow-up draw in 3 to 6 months
2.0 to 2.9	Moderate insulin resistance	Elevated cardiovascular and type 2 diabetes risk; clinical workup warranted
3.0 and above	Significant insulin resistance	Common in prediabetes and metabolic syndrome; often coexists with elevated triglycerides

The population average in the US sits around 1.3 to 1.5 in studies of non-diabetic adults. That average is not the target. A study published in Diabetes Care examining over 14,000 subjects found that HOMA-IR above 2.0 was independently associated with cardiovascular events even when fasting glucose was still technically normal. Optimizing toward below 1.0 is a reasonable goal for anyone focused on metabolic longevity.

Children and adolescents have different reference ranges; puberty transiently raises HOMA-IR by 30 to 50 percent due to growth hormone surges. Applying adult cutoffs to a 14-year-old will generate false alarms.

What Raises HOMA-IR? The Biology Behind the Number

Insulin resistance at the cellular level precedes a rising HOMA-IR score by years. Muscle, liver, and fat tissue all express insulin receptors, but they become desensitized through different mechanisms. Ectopic fat accumulation in the liver (hepatic steatosis) is one of the earliest drivers. Even a small increase in intrahepatic lipid content blunts insulin signaling in the hepatocytes, which then fail to suppress glucose output overnight. That raises fasting glucose modestly, but the pancreas compensates with more insulin, and the ratio climbs before glucose alone crosses any threshold.

The main modifiable contributors:

• Visceral adiposity: fat stored around the organs secretes inflammatory cytokines (TNF-alpha, IL-6) that directly antagonize insulin receptor signaling
• Sedentary muscle: skeletal muscle is the body’s largest glucose sink; inactive muscle downregulates GLUT4 transporters, reducing insulin-stimulated uptake
• Processed carbohydrate load: repeated post-meal glucose spikes demand repeated high-dose insulin pulses, gradually desensitizing receptors
• Sleep disruption: even one night of partial sleep deprivation raises fasting insulin measurably; chronic poor sleep is a consistent predictor of rising HOMA-IR
• Cortisol excess: chronic psychological stress, shift work, or endogenous hypercortisolism (Cushing syndrome) drives hepatic glucose output and impairs peripheral insulin action simultaneously

Non-modifiable contributors include genetic variants in the IRS1 gene and polycystic ovary syndrome (PCOS), where androgen excess worsens insulin signaling independently of body weight. Women with PCOS frequently have HOMA-IR scores of 3 to 5 even at normal BMI, a pattern that is often missed when only fasting glucose is checked.

Signs of Insulin Resistance You Can Notice Before the Lab

Insulin resistance is mostly silent, which is the whole reason a number is worth having. But there are soft signals that should make you want the test rather than wait for symptoms. A stubborn ring of belly fat that will not budge on the same diet that used to work, energy crashes and cravings an hour or two after a carb-heavy meal, and afternoon slumps that a snack only briefly fixes are all consistent with the pancreas working overtime. So is skin tenderness like dark, velvety patches at the neck or armpits, called acanthosis nigricans, and clusters of small skin tags, both of which track with high insulin. In women, irregular cycles, acne, and unwanted hair growth point toward the PCOS pattern above. None of these confirm insulin resistance on their own, but if two or three show up, a fasting insulin and glucose draw is a cheap way to stop guessing.

Consider a common case. A 34-year-old woman at a normal BMI comes in frustrated that her weight has crept up despite eating carefully, with irregular periods and afternoon crashes. Her fasting glucose reads a reassuring 88 mg/dL, so a standard panel calls her healthy. Add a fasting insulin of 16 microIU/mL and the HOMA-IR is 3.48, squarely insulin resistant and consistent with PCOS. Nothing on the basic panel would have flagged it. That gap between a normal glucose and a genuinely resistant metabolism is the exact problem HOMA-IR was built to catch.

HOMA-IR vs Fasting Insulin: Which One Should You Track?

Fasting insulin alone already tells you a great deal, and some clinicians prefer it for simplicity. HOMA-IR adds glucose to the equation because a person with low insulin and high glucose (early type 1 autoimmune) looks very different from a person with high insulin and normal glucose (early type 2). The ratio separates these patterns.

Here is the practical breakdown:

Marker	What It Captures	Optimal Value	Best Use Case
Fasting Insulin	Pancreatic output at rest	Below 6 to 8 microIU/mL (functional medicine consensus)	Quickest single-number screen; needs context
Fasting Glucose	Blood sugar regulation at rest	70 to 85 mg/dL (optimal range)	Standard metabolic screen; late-stage signal
HOMA-IR	Insulin-glucose balance as a system	Below 1.0	Best for trending over time and research comparisons
A1C	Average glucose over ~90 days	Below 5.3% (optimal)	Catches sustained hyperglycemia; misses early insulin resistance

A fasting insulin of 12 microIU/mL with a glucose of 78 mg/dL gives a HOMA-IR of 2.31, flagging insulin resistance despite an A1C that might still read 5.1 percent. That gap between what A1C reports and what the body is actually doing is exactly why tracking the fasting insulin marker matters. Checking both markers costs $30 to $60 extra compared to a standard chemistry panel, and the yield is disproportionately high.

If you are already getting blood drawn anyway, it is often smarter to capture a full metabolic baseline at once. Here is how a full-body panel compares to piecemeal ordering.

How to Get Your HOMA-IR Tested in 2026

No US lab runs a “HOMA-IR test” as a single line item. You order the two components separately: a fasting insulin and a fasting glucose (or a fasting comprehensive metabolic panel that already includes glucose). The calculation is then done manually or with an online calculator.

Your options in order of cost:

1. Direct-access lab ordering: Quest Diagnostics and Labcorp both allow self-pay ordering through their patient portals or third-party services like Ulta Lab Tests and Walk-In Lab. Fasting insulin runs $25 to $65 cash pay. A fasting metabolic panel including glucose runs $10 to $30. Total out-of-pocket: $35 to $95, no doctor order required in most states.
2. Primary care or endocrinologist: Request “fasting insulin” specifically. Many physicians do not order it by default because it is not part of standard preventive care billing codes. You may need to ask twice. With insurance, copays and deductibles vary widely; uninsured patients can negotiate the direct-pay rates above.
3. Comprehensive longevity panels: Services that bundle 50 to 100 biomarkers in a single draw (including fasting insulin and glucose) typically run $200 to $500 cash but give you the full metabolic picture in one visit. This makes HOMA-IR calculation automatic as part of a broader complete blood panel.
4. CVS MinuteClinic and urgent care: Some locations offer metabolic panels that include glucose but rarely include fasting insulin. Call ahead before going; the fasting requirement also means you need an early-morning appointment.

HSA and FSA funds can generally be applied to lab tests ordered for diagnostic purposes. If your employer HSA has a debit card, most lab collection sites accept it directly. Medicare covers fasting glucose as part of the Welcome to Medicare visit, but fasting insulin is typically not covered without a documented clinical indication such as hypoglycemic episodes or suspected diabetes.

How to Prep So Your HOMA-IR Is Accurate

Because the score multiplies two fasting values, sloppy prep can swing it more than a real change in your metabolism. Fasting insulin in particular is sensitive, so the details matter. A few rules keep the number honest:

• Fast a true 10 to 12 hours. Eight hours is the minimum, but insulin has not fully returned to baseline at eight in some people. Water is fine. Black coffee is not, because caffeine can transiently raise both glucose and insulin, so skip it until after the draw.
• Draw in the early morning. Both glucose and insulin follow a daily rhythm, and morning fasting values are the ones the reference ranges were built on. A late-morning “fasting” draw after you have been awake and moving for hours is not the same measurement.
• Skip hard exercise the day before. A single intense workout improves insulin sensitivity for 24 to 48 hours and can push your HOMA-IR temporarily low, which flatters the number. If you want your true baseline, test on a normal, non-training morning rather than the day after a rest week or the day after a marathon.
• Do not test during acute illness or right after a bad night. Infection, injury, and even one short night of sleep raise insulin through stress hormones. A cold or a red-eye flight can add a point to your score that has nothing to do with your long-term metabolism.
• Note your medications and cycle. Steroids, some antipsychotics, and high-dose niacin raise insulin resistance, while the luteal phase of the menstrual cycle nudges it up slightly. None of these need to be stopped, but they belong in the interpretation.

The single biggest avoidable error is treating a stressed, post-workout, or poorly slept draw as your baseline. If a result surprises you, the right move is a clean repeat under standard conditions before you act on it.

How to Lower HOMA-IR: What Actually Moves the Number

HOMA-IR responds to lifestyle changes faster than most patients expect. A well-designed intervention study can drop HOMA-IR by 30 to 50 percent in 8 to 12 weeks. The levers, roughly ranked by effect size:

Resistance Training

Skeletal muscle is the dominant site of insulin-stimulated glucose disposal. Progressive resistance training increases GLUT4 transporter density in muscle cells, improving insulin sensitivity independently of weight loss. Two to three sessions per week of compound movements (squat, hinge, press, pull) produces measurable HOMA-IR reduction within six to eight weeks in sedentary adults.

Low-Glycemic and Time-Restricted Eating

Reducing the frequency and amplitude of post-meal glucose spikes gives the pancreas time to bring insulin back to baseline between meals. Time-restricted eating (eating within a 6 to 10-hour window) compounds this by extending the nightly fasting period, which forces the body to rely on fat oxidation and allows insulin to stay low for a longer stretch each day. The specific macronutrient split matters less than reducing ultra-processed carbohydrates and seed oils, which appear to disrupt insulin signaling at the receptor level.

Sleep Quality

Targeting 7 to 9 hours of consolidated sleep is not soft advice. Sleep restriction studies show that restricting sleep to 5.5 hours for two weeks raises fasting insulin by 20 to 30 percent in healthy volunteers. Obstructive sleep apnea is a particularly high-yield intervention target: treating it with CPAP consistently lowers HOMA-IR even without dietary changes.

Visceral Fat Reduction

Losing 5 to 10 percent of body weight, particularly visceral fat, is one of the most powerful HOMA-IR reducers. Visceral fat responds faster to caloric deficit and exercise than subcutaneous fat, which is partly why HOMA-IR often improves before the scale moves much.

Tracking the best biomarkers to test alongside HOMA-IR (triglycerides, fasting insulin, adiponectin) gives you a fuller picture of whether your interventions are working at the cellular level. When HOMA-IR comes down, triglycerides usually fall and HDL usually rises in parallel, which is a useful cross-check that the improvements are real.

HOMA-IR and Related Metabolic Markers: Reading the Full Pattern

HOMA-IR does not exist in isolation. Insulin resistance tends to show up across multiple biomarkers simultaneously, and recognizing the cluster makes the diagnosis far more convincing than any single number.

The classic insulin resistance panel pattern:

• HOMA-IR above 2.0
• Fasting triglycerides above 150 mg/dL (often above 200)
• HDL cholesterol below 50 mg/dL in women or below 40 mg/dL in men
• Fasting glucose 90 to 99 mg/dL (technically normal but trending up)
• Uric acid above 6 mg/dL (a byproduct of fructose metabolism that tracks with insulin resistance)
• Low adiponectin (a fat-cell hormone that protects against insulin resistance; its levels fall as visceral fat accumulates)

If three or more of these markers are off simultaneously, the insulin resistance signal is reliable even if HOMA-IR alone is borderline. Conversely, a HOMA-IR of 2.1 with perfect triglycerides, high HDL, and a glucose of 78 should prompt a repeat test before major clinical decisions, since fasting insulin assay variability alone can shift the score by 15 to 20 percent.

Elevated liver enzymes (AST, ALT) frequently accompany high HOMA-IR because the same ectopic fat that causes hepatic insulin resistance also causes non-alcoholic fatty liver disease (NAFLD). A high HOMA-IR with elevated ALT is a reasonable indication for a liver ultrasound even in the absence of other liver symptoms.

FAQ

What is a good HOMA-IR score?

Below 1.0 is considered optimal by most longevity-focused clinicians and is associated with the lowest metabolic disease risk in observational data. The US population average sits around 1.3 to 1.5 in non-diabetic adults, but average is not optimal. Scores above 2.0 are the threshold most research papers use to define insulin resistance.

Can I calculate HOMA-IR from my existing lab results?

Yes, if you have a fasting insulin and a fasting glucose from the same blood draw. Use the formula: (fasting insulin in microIU/mL x fasting glucose in mg/dL) / 405. If your lab reports glucose in mmol/L, divide by 22.5 instead. The two values must both be fasting, taken after at least 8 hours with no calories.

How accurate is HOMA-IR compared to a glucose clamp test?

The hyperinsulinemic-euglycemic clamp is the gold standard for measuring insulin resistance, but it is invasive, expensive, and impractical outside research settings. HOMA-IR correlates with clamp-measured insulin sensitivity at approximately r = 0.88 in most validation studies, which is strong enough for clinical and population use. Its main weakness is fasting insulin assay variability across labs.

Does HOMA-IR work for people who take metformin or insulin?

Not reliably. Metformin directly suppresses hepatic glucose output, which lowers fasting glucose and artificially improves the HOMA-IR calculation without necessarily reflecting improved peripheral insulin sensitivity. Exogenous insulin administration makes fasting insulin values meaningless for this formula. In both cases, other markers (fasting C-peptide, continuous glucose monitoring patterns) give better signal.

How often should I retest HOMA-IR?

If your baseline is above 2.0 and you are making active changes (diet, exercise, sleep), retesting every 8 to 12 weeks is reasonable to confirm your interventions are working. Once you are in the optimal range and lifestyle is stable, an annual check as part of a broader metabolic panel is sufficient. More frequent testing than every 6 to 8 weeks rarely adds useful information given the inherent assay variability.

Why does my doctor not order fasting insulin routinely?

Fasting insulin is not included in any standard preventive care order set and is not reimbursed by Medicare or most commercial insurers as a routine screening test. Physicians work from standardized order panels, and insulin was never added to them. This is a structural gap in US preventive care, not a reflection of the marker’s validity. You can request it specifically, or order it directly through a self-pay lab service.

What is the difference between HOMA-IR and HOMA-beta?

The HOMA model actually produces two outputs. HOMA-IR estimates insulin resistance. HOMA-beta estimates pancreatic beta-cell function (how much insulin-producing capacity remains). HOMA-beta = (20 x fasting insulin) / (fasting glucose minus 3.5). Clinically, HOMA-IR gets most of the attention for metabolic risk, while HOMA-beta is more relevant in research on type 2 diabetes progression and beta-cell preservation.

Can a single low-carb day or a hard workout fake a good HOMA-IR?

To a degree, yes, which is why prep matters. A day of very low carbohydrate intake lowers fasting insulin, and a hard workout improves insulin sensitivity for a day or two, so testing right after either can make your score look better than your true baseline. This is not cheating your health, just cheating the measurement. If you want a number that reflects your everyday metabolism, test on a normal, non-training morning after a typical few days of eating, not after a deliberate reset.

My HOMA-IR is borderline. Should I panic or wait?

Neither. A borderline score between 1.5 and 2.0, or a lone 2.1 with otherwise clean triglycerides, HDL, and glucose, is a signal to act on habits and recheck, not a diagnosis. Given that fasting insulin assays can shift a score by 15 to 20 percent, repeat the draw under clean conditions in 8 to 12 weeks after tightening sleep, movement, and processed carbs. If the second clean result is still elevated, or if it climbs alongside triglycerides and liver enzymes, that is the point to bring it to a clinician.

Can someone have a normal A1C but a high HOMA-IR?

Yes, and this is one of the most clinically important use cases for the test. A1C only rises when average glucose has been elevated for months. HOMA-IR rises years earlier, when the pancreas is compensating with excess insulin to keep glucose in the normal range. A person with an A1C of 5.2 and a HOMA-IR of 3.1 is not metabolically healthy. They are in the compensation phase that precedes prediabetes, and that window is when intervention is most effective. If you are getting a complete blood panel, adding fasting insulin to the draw costs very little extra and closes this diagnostic gap entirely.